Categories
Business Chemical

Advancements in Molecular Diagnostics: PCR and Real-time PCR Revolutionize the Industry

Molecular diagnostics has emerged as a pivotal player in modern healthcare, revolutionizing disease detection, monitoring, and research. Polymerase Chain Reaction (PCR) and its refined counterpart, Real-time PCR, have significantly transformed the diagnostics industry. These powerful techniques offer unparalleled sensitivity, accuracy, and speed, enabling scientists and healthcare professionals to detect and quantify genetic material with remarkable precision.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=5247?AS 

Understanding PCR and Real-time PCR

Polymerase Chain Reaction (PCR): PCR is a widely-used molecular biology technique developed in the 1980s by Kary B. Mullis. It allows the amplification of a specific segment of DNA through a series of temperature-controlled reactions. The process involves denaturation, annealing, and extension, resulting in the exponential replication of the target DNA region.

Real-time PCR: Also known as quantitative PCR (qPCR), real-time PCR builds upon the basic PCR principle by allowing continuous monitoring of the amplification process. It employs fluorescent dyes or probes that emit signals when they bind to the target DNA, enabling the quantification of the amplified DNA in real-time. This real-time monitoring eliminates the need for post-amplification analysis, making the technique faster and more precise.

Applications in Molecular Diagnostics

  1. Infectious Disease Diagnosis: PCR and real-time PCR have revolutionized the diagnosis of infectious diseases by detecting specific pathogen DNA or RNA. This has greatly improved the accuracy and speed of diagnosing viral, bacterial, and fungal infections. For instance, during the COVID-19 pandemic, real-time PCR played a pivotal role in diagnosing SARS-CoV-2 infections.
  2. Cancer Detection and Monitoring: These techniques have enabled the identification of genetic mutations associated with various cancers. Real-time PCR is particularly valuable in monitoring minimal residual disease, allowing clinicians to gauge treatment efficacy and recurrence risk in cancer patients.
  3. Genetic Testing: PCR-based diagnostics are extensively used in genetic testing, including prenatal screening, carrier testing, and diagnosing genetic disorders. Real-time PCR’s ability to quantify gene expression levels has furthered our understanding of genetic variations and their implications.
  4. Forensic Identification: PCR has revolutionized forensic science by enabling the analysis of small DNA samples from crime scenes. DNA fingerprinting, a technique that uses PCR to amplify specific DNA regions, has become a cornerstone in criminal investigations.
  5. Food Safety and Environmental Monitoring: PCR-based assays are employed to detect foodborne pathogens and monitor environmental contaminants. Real-time PCR’s accuracy and speed make it an ideal tool for ensuring the safety of food and water supplies.

PCR and real time pcr molecular diagnostics market forecast by Fact.MR

Impact on the Industry

  1. Accuracy and Sensitivity: PCR and real-time PCR offer unparalleled accuracy and sensitivity, enabling the detection of even minute amounts of genetic material. This is crucial for early disease detection and monitoring.
  2. Speed: Real-time PCR’s ability to provide results in real-time significantly reduces the turnaround time for diagnostics, allowing for quicker patient management and informed decision-making.
  3. Automation: Automated platforms have streamlined the PCR and real-time PCR processes, reducing the chances of human error and increasing throughput in clinical laboratories.
  4. Research Advancements: These techniques have revolutionized research in genetics, genomics, and molecular biology. They enable researchers to study gene expression, mutations, and variations with precision, leading to insights into disease mechanisms and potential therapeutic targets.

Conclusion

The Polymerase Chain Reaction (PCR) and Real-time PCR have transformed the landscape of molecular diagnostics. Their applications span across infectious disease diagnosis, cancer monitoring, genetic testing, forensics, food safety, and environmental monitoring. The industry owes a debt of gratitude to these techniques for their accuracy, sensitivity, speed, and impact on medical research and patient care. As technology continues to evolve, we can only anticipate further refinements and applications of these powerful tools in the realm of molecular diagnostics.

Categories
Pharmaceutical

PCR and Real-time PCR Molecular Diagnostics Market: North America is Expected to Remain Highly Promising and Hold a Prominent Market Share

250 Pages PCR and Real-time PCR Molecular Diagnostics Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of PCR and Real-time PCR Molecular Diagnostics to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, PCR and Real-time PCR Molecular Diagnostics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=5247

As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular testing technologies for fast real-time results and automated operations, with minimal risks of false positives and negatives.

PCR and real-time PCR molecular diagnostics is also finding growing roles in a number of other healthcare sectors, including forensics and genetics, which are likely to bode well for the PCR and real-time PCR molecular diagnostics market in the foreseeable future. Digital PCR, in particular, is projected to reflect fast growth, owing to higher accuracy and sensitivity in the quantification of molecular materials.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of PCR and Real-time PCR Molecular Diagnostics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of PCR and Real-time PCR Molecular Diagnostics

pcr and real time pcr molecular diagnostics market analysis and forecast by technology

The report offers actionable and valuable market insights of PCR and Real-time PCR Molecular Diagnostics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of PCR and Real-time PCR Molecular Diagnostics Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5247

PCR and Real-time PCR Molecular Diagnostics Market: Segmentation

Fact.MR has studied the PCR and real-time PCR molecular diagnostics market with detailed segmentation on the basis of technology, product, application, end user, and key regions.

Technology

  • Traditional PCR
  • Real-time PCR
  • Digital PCR

Product

  • Instruments
  • Reagents
  • Consumables

Application

  • Infectious Diseases Testing
    • HCV and HBV
    • Sexually Transmitted Infections
    • Hospital Acquired Infection
    • Respiratory Infections
    • Others
  • Oncology Testing
  • Genetic Testing
  • Others

End User

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Centers
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/5247

Key Takeaways from PCR and Real-time PCR Molecular Diagnostics Market Report

  • Real-time PCR technologies are estimated to hold major market share, supported by higher research & development investments by market players and improved awareness about molecular diagnostics among patients and healthcare professionals.
  • North America is the leading regional markets for PCR and real-time PCR molecular diagnostics, followed by Europe, owing to faster regulatory approvals and access to new healthcare technologies.
  • Oncology diagnostics is expected to surge in the near future driven by growing number of patients and investments towards modernization of healthcare facilities with government aid, providing impetus to the PCR and real-time PCR molecular diagnostics market in emerging economies.
  • The COVID-19 outbreak, which has had a worldwide impact, is projected to positively influence the prospects of the PCR and real-time PCR molecular diagnostics market, aided by emergency authorization for new products being given by regulatory bodies.

“Widespread incidence of target ailments, including cancer and COVID-19, coupled with technological advancements for faster results and automated work processes are likely to provide leverage to the PCR and real-time PCR molecular diagnostics market in the long term,” says a Fact.MR analyst.

Key Players Focus on New Product Launches and Regulatory Approval

Abbott Laboratories, Elekta AB Bio-Rad Laboratories Inc., bioMerieux SA, Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, F.Hoffmann-La Roche Ltd., Qiagen NV, Hologic Inc, Grifols SA, Genomic Health,  and Seegene Inc. are some of the more prominent players operating in the PCR and real-time PCR molecular diagnostics market. Leading market players have been observed investing significant resources towards product development and launch strategies, and pushing for faster regulatory approvals to gain an edge over the competition. Market players are also focused on leveraging short term opportunities arising from the COVID-19 pandemic.

  • For instance, in October 2020, Abbott Laboratories announced the receipt of FDA approval for its PCR covid-19 antigen test, under emergency use authorization, for the company’s BinaxNow COVID-19 Ag Card, which provides rapid results similar to an over-the-counter pregnancy test.
  • BioMérieux has also announced regulatory clearance for its Vitek 2 AST Gram Negative Ceftazidime test, to trace gram-negative bacilli bacteria, which is compatible with the company’s proprietary Vitek 2 Compact and Vitek 2 molecular diagnostics platforms.
  • Similarly, Roche Diagnostics has also received FDA approval for its Cobas RT-PCR test, aimed at detecting the BK virus, which is designed to run alongside the business’ Cobas 8800 and 6800 diagnostic platforms.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • PCR and Real-time PCR Molecular Diagnostics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • PCR and Real-time PCR Molecular Diagnostics Historical volume analysis: The report provides a comparison of PCR and Real-time PCR Molecular Diagnostics’s historical sales and projected sales performance for 2021-2031.
  • PCR and Real-time PCR Molecular Diagnostics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the PCR and Real-time PCR Molecular Diagnostics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • PCR and Real-time PCR Molecular Diagnostics Consumption by demographics: The report investigates consumer behavior affecting PCR and Real-time PCR Molecular Diagnostics demand outlook for the assessment period. Effect of their keenness for digital trends on PCR and Real-time PCR Molecular Diagnostics market is carefully analyzed
  • Post COVID consumer spending on PCR and Real-time PCR Molecular Diagnostics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting PCR and Real-time PCR Molecular Diagnostics market growth.

More Valuable Insights on PCR and Real-time PCR Molecular Diagnostics Market

Fact.MR, in its new report, offers an unbiased Market Analysis of PCR and Real-time PCR Molecular Diagnostics, Sales and Demand of PCR and Real-time PCR Molecular Diagnostics, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Demand For PCR And Real-Time PCR Molecular Diagnostics Is Set To Grow At A Higher Pace Over The Medium- And Long-Run Forecast Period 2022-2032

PCR and Real-time PCR Molecular Diagnostics Market Overview

In recent years, uptake of polymerase chain reaction (PCR) molecular diagnostics has experienced substantial increase. PCR tests are highly effective in detecting pathogenic DNA for several contagious diseases. Efforts are underway to improve the scope of PCR and RT-PCR tests to discover treatments for life-threatening ailments.

The COVID-19 pandemic has especially bolstered prospects for the expansion of the PCR and real-time PCR molecular diagnostics market size. Various healthcare settings have deployed real-time (qPCR) and digital (dPCR) PCR tests to detect and diagnose possible cases. Its highly sensitive nature has led healthcare providers to adopt PCR tests on a large scale. On the back of such trends, the global PCR and real-time PCR molecular diagnostics market is set to reach new heights, surpassing an impressive revenue threshold in the coming decade.

Request Sample  –https://www.factmr.com/connectus/sample?flag=S&rep_id=5247

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth.

Digital Transformation in Healthcare Presenting Opportunities for PCR and Real-time PCR Molecular Diagnostics Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the PCR and Real-time PCR Molecular Diagnostics market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of PCR and Real-time PCR Molecular Diagnostics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of PCR and Real-time PCR Molecular Diagnostics

The report offers actionable and valuable market insights of PCR and Real-time PCR Molecular Diagnostics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of PCR and Real-time PCR Molecular Diagnostics Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of PCR and Real-time PCR Molecular Diagnostics, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of PCR and Real-time PCR Molecular Diagnostics Market.

PCR and Real-time PCR Molecular Diagnostics Market: Segmentation

Fact.MR has studied the PCR and real-time PCR molecular diagnostics market with detailed segmentation on the basis of technology, product, application, end user, and key regions.

Technology

  • Traditional PCR
  • Real-time PCR
  • Digital PCR

Product

  • Instruments
  • Reagents
  • Consumables

Application

  • Infectious Diseases Testing
    • HCV and HBV
    • Sexually Transmitted Infections
    • Hospital Acquired Infection
    • Respiratory Infections
    • Others
  • Oncology Testing
  • Genetic Testing
  • Others

 Report Methodology- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5247

End User

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Centers
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

PCR and Real-time PCR Molecular Diagnostics Market – Scope of the Report

A new report by Fact.MR on the PCR and real-time PCR molecular diagnostics market provides a 10-year forecast analysis for the period of 2020 to 2030. The study covers key trends that are influencing the growth of the PCR and real-time PCR molecular diagnostics market. This report explicates on key dynamics, including the drivers, restraints, and opportunities for leading market players in addition to major stakeholders and new players associated with the services of PCR and real-time PCR molecular diagnostics. The study also discusses the dynamics responsible for affecting the future of the PCR and real-time PCR molecular diagnostics market over the assessment period.

A detailed scrutiny of PCR and real-time PCR molecular diagnostics business execution, value chain analysis, and supply chain analysis across regional markets has been provided. A list of major companies operating in the PCR and real-time PCR molecular diagnostics market along with their product portfolios boosts the reliability of this research report.

Buy Now  https://www.factmr.com/checkout/5247

PCR and Real-time PCR Molecular Diagnostics Market: Report Summary

The study offers comprehensive analysis on diverse features, including product developments, demand, sales, and revenue generation in the global PCR and real-time PCR molecular diagnostics market.

An in-depth estimate on the PCR and real-time PCR molecular diagnostics market has been given through optimistic and conservative scenarios, encompassing the sales of PCR and real-time PCR molecular diagnostics during the forecast period. Region-wise price point comparison and data on global average price is also covered in the study.

PCR and Real-time PCR Molecular Diagnostics Market: Analysis on Market Size Evaluation

The PCR and real-time PCR molecular diagnostics market has been analyzed for each market segment in terms of value (US$ Mn).

Market estimates for global and regional levels for PCR and real-time PCR molecular diagnostics are provided in the report in terms of “US$ Mn” for value. A Y-o-Y growth analysis on major PCR and real-time PCR molecular diagnostics market segments, in addition to an evaluation of market attractiveness, has been added to the report. Also, absolute dollar opportunity analysis of the segments boosts the scope of the report. Absolute dollar opportunity plays a critical role in the assessment of opportunities that manufacturers/distributors can achieve, with the identification of potential resources, covering sales and distribution in the global PCR and real-time PCR molecular diagnostics market.

PCR and Real-time PCR Molecular Diagnostics Market: Inspected Assessment on Regional Segments

Key sections have been elaborated on the PCR and real-time PCR molecular diagnostics market report, in terms of projections for regional markets. These chapters include regional macros (economic, political and business environment), which are projected to notably influence the growth of the PCR and real-time PCR molecular diagnostics market during the forecast period.

Country-specific evaluation for PCR and real-time PCR molecular diagnostics has been given for every regional market, with estimates on market scope and forecasts, impact analysis, and price index of the dynamics in regions and countries. Y-o-Y estimates have been added for all regional markets. Detailed analysis in terms of value and volume for emerging regional markets have also been added to the report.

PCR and Real-time PCR Molecular Diagnostics Market: In-depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of PCR and real-time PCR molecular diagnostics, along with detailed profiles. Important and up-to-date information related to market performers who are largely engaged in the services of PCR and real-time PCR molecular diagnostics has been discussed with the aid of a detailed dashboard view. Market share analysis and comparison of the top players allows report readers to take preemptive steps in boosting their businesses.

Key Takeaways from PCR and Real-time PCR Molecular Diagnostics Market Report

  • Real-time PCR technologies are estimated to hold major market share, supported by higher research & development investments by market players and improved awareness about molecular diagnostics among patients and healthcare professionals.
  • North America is the leading regional markets for PCR and real-time PCR molecular diagnostics, followed by Europe, owing to faster regulatory approvals and access to new healthcare technologies.
  • Oncology diagnostics is expected to surge in the near future driven by growing number of patients and investments towards modernization of healthcare facilities with government aid, providing impetus to the PCR and real-time PCR molecular diagnostics market in emerging economies.
  • The COVID-19 outbreak, which has had a worldwide impact, is projected to positively influence the prospects of the PCR and real-time PCR molecular diagnostics market, aided by emergency authorization for new products being given by regulatory bodies.

“Widespread incidence of target ailments, including cancer and COVID-19, coupled with technological advancements for faster results and automated work processes are likely to provide leverage to the PCR and real-time PCR molecular diagnostics market in the long term,” says a Fact.MR analyst.


Report Benefits & Key Questions Answered

  • PCR and Real-time PCR Molecular Diagnostics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • PCR and Real-time PCR Molecular Diagnostics Historical volume analysis: The report provides a comparison of PCR and Real-time PCR Molecular Diagnostics’s historical sales and projected sales performance for 2021-2031.
  • PCR and Real-time PCR Molecular Diagnostics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the PCR and Real-time PCR Molecular Diagnostics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • PCR and Real-time PCR Molecular Diagnostics Consumption by demographics: The report investigates consumer behavior affecting PCR and Real-time PCR Molecular Diagnostics demand outlook for the assessment period. Effect of their keenness for digital trends on PCR and Real-time PCR Molecular Diagnostics market is carefully analyzed
  • Post COVID consumer spending on PCR and Real-time PCR Molecular Diagnostics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting PCR and Real-time PCR Molecular Diagnostics market growth.

More Valuable Insights on PCR and Real-time PCR Molecular Diagnostics Market

Fact.MR, in its new report, offers an unbiased Market Analysis of PCR and Real-time PCR Molecular Diagnostics, Sales and Demand of PCR and Real-time PCR Molecular Diagnostics, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

For More Insights- https://www.einpresswire.com/article/557050928/demand-for-subscription-based-transportation-management-systems-is-surging-as-clients-need-a-solution-cum-service-bundle

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Uptake of RT-PCR Tests Is Surged Amid the COVID-19 pandemic : Report Fact.MR

As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular testing technologies for fast real-time results and automated operations, with minimal risks of false positives and negatives.

PCR and real-time PCR molecular diagnostics is also finding growing roles in a number of other healthcare sectors, including forensics and genetics, which are likely to bode well for the PCR and real-time PCR molecular diagnostics market in the foreseeable future. Digital PCR, in particular, is projected to reflect fast growth, owing to higher accuracy and sensitivity in the quantification of molecular materials.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=5247

“Widespread incidence of target ailments, including cancer and COVID-19, coupled with technological advancements for faster results and automated work processes are likely to provide leverage to the PCR and real-time PCR molecular diagnostics market in the long term,” says a Fact.MR analyst.

pcr and real time pcr molecular diagnostics market analysis and forecast by technology

Key Takeaways from PCR and Real-time PCR Molecular Diagnostics Market Report

  • Real-time PCR technologies are estimated to hold major market share, supported by higher research & development investments by market players and improved awareness about molecular diagnostics among patients and healthcare professionals.
  • North America is the leading regional markets for PCR and real-time PCR molecular diagnostics, followed by Europe, owing to faster regulatory approvals and access to new healthcare technologies.
  • Oncology diagnostics is expected to surge in the near future driven by growing number of patients and investments towards modernization of healthcare facilities with government aid, providing impetus to the PCR and real-time PCR molecular diagnostics market in emerging economies.
  • The COVID-19 outbreak, which has had a worldwide impact, is projected to positively influence the prospects of the PCR and real-time PCR molecular diagnostics market, aided by emergency authorization for new products being given by regulatory bodies.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5247

Global PCR and Real-time PCR Molecular Diagnostics Market: Segmentation

Technology

  • Traditional PCR
  • Real-time PCR
  • Digital PCR

Product

  • Instruments
  • Reagents
  • Consumables

Application

  • Infectious Diseases Testing
    • HCV and HBV
    • Sexually Transmitted Infections
    • Hospital Acquired Infection
    • Respiratory Infections
    • Others
  • Oncology Testing
  • Genetic Testing
  • Others

End User

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Centers
  • Others

Following Questions Answers Covered in the Report are:

  • How will the global PCR and Real-time PCR Molecular Diagnostics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global PCR and Real-time PCR Molecular Diagnostics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global PCR and Real-time PCR Molecular Diagnostics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5247

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Key Players Focus on New Product Launches and Regulatory Approval

Abbott Laboratories, Elekta AB Bio-Rad Laboratories Inc., bioMerieux SA, Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, F.Hoffmann-La Roche Ltd., Qiagen NV, Hologic Inc, Grifols SA, Genomic Health,  and Seegene Inc. are some of the more prominent players operating in the PCR and real-time PCR molecular diagnostics market. Leading market players have been observed investing significant resources towards product development and launch strategies, and pushing for faster regulatory approvals to gain an edge over the competition. Market players are also focused on leveraging short term opportunities arising from the COVID-19 pandemic.

  • For instance, in October 2020, Abbott Laboratories announced the receipt of FDA approval for its PCR covid-19 antigen test, under emergency use authorization, for the company’s BinaxNow COVID-19 Ag Card, which provides rapid results similar to an over-the-counter pregnancy test.
  • BioMérieux has also announced regulatory clearance for its Vitek 2 AST Gram Negative Ceftazidime test, to trace gram-negative bacilli bacteria, which is compatible with the company’s proprietary Vitek 2 Compact and Vitek 2 molecular diagnostics platforms.
  • Similarly, Roche Diagnostics has also received FDA approval for its Cobas RT-PCR test, aimed at detecting the BK virus, which is designed to run alongside the business’ Cobas 8800 and 6800 diagnostic platforms.

Get More Insights –http://www.globenewswire.com/en/news-release/2018/03/01/1409052/0/en/3-Key-Future-Prospects-of-Autoclaved-Aerated-Concrete-Market-for-the-Forecast-Period-2017-2026.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com